パンカタリティック医学:非毒性疾患治療のパラダイム
1Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|September 4, 2025
まとめ
パンカタリティック・セラピー (PCT) は,病気の部位に触媒を正確に送ることによって,無毒な治療法を提供します. この方法は,病理的な環境を標的として,体生態を保ち,より安全で効果的な病気管理のために副作用を最小限に抑え,インサイト反応を活性化します.
科学分野:
- 生物医学工学
- 触媒科学
- 環境医学
背景:
- 伝統的な病気の治療には しばしば有毒な薬や 侵襲的な手術が含まれており 効果が低く 副作用も大きいのです
- 身体の自然な生態的バランスを維持する 毒性のない治療法が必要なのです
研究 の 目的:
- パンカタリティック・メディシン (PM) を新しい,無毒の治療法として導入し,定義する.
- PMの原理とメカニズムを明らかにし,身体の生態学との統合を強調する.
- PMの潜在力を強調し,安全性を高め,標的を絞った疾患治療を実現する.
主な方法:
- 触媒の準備 (P):標的を特定した触媒の開発.
- 生物学的効果の活性化 (A):病原点における触媒を活性化するための戦略.
- 汎用性疾患の非毒性治療 (N):病理学的微環境に対する触媒反応の適用.
主要な成果:
- PMは病原点で 癌や炎症のような病理的状態を標的とした 精密な触媒反応を可能にします
- このアプローチは,特定の病理的マイクロ環境内でのみ触媒を活性化することによって,標的外毒性を最小限に抑えます.
- PMは正常な組織ホメオスタシスと身体の全体的な生態的バランスを効果的に維持します.
結論:
- パンカタリティック・セラピー (PCT) は,疾患の治療におけるパラダイムシフトであり,特異性と安全性を高めるための生態学的原理を統合しています.
- PCTは 副作用が少ない 毒性のない治療法の開発に革命的な方向性をもたらします
- このアプローチは,特に慢性的で複雑な疾患の管理において,将来の医学的な応用において,大きな希望を秘めています.
関連する概念動画
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Chronic Pancreatitis II: Collaborative Care
127
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
127
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Antidotes
755
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
755


